Option Care Health (NASDAQ:OPCH) Price Target Raised to $38.00

Option Care Health (NASDAQ:OPCH) had its price objective upped by Barrington Research from $33.00 to $38.00 in a report issued on Thursday morning,Benzinga reports. Barrington Research currently has an outperform rating on the stock.

A number of other equities analysts also recently commented on OPCH. UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $32.88.

Option Care Health Stock Up 0.9 %

NASDAQ:OPCH opened at $33.50 on Thursday. The company has a market capitalization of $5.70 billion, a price-to-earnings ratio of 28.15, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. Option Care Health has a one year low of $21.39 and a one year high of $34.17. The stock has a 50-day simple moving average of $28.70 and a 200 day simple moving average of $28.08. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health during the fourth quarter worth approximately $26,000. UMB Bank n.a. boosted its position in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares during the period. Signaturefd LLC boosted its position in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC boosted its position in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after buying an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its position in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after buying an additional 332 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.